tolvaptan

Spain

Drugs containing this active substance

  • JINARC 15 MG + 45 MG TABLETS

    It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 45 mg
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 60 mg
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of kidney cysts, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 90 mg
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stage 1 to 4) who show signs of rapidly progressing disease. It helps slow the development of kidney cysts, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat low sodium levels in the blood in adults as a result of syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 10 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 7, 50 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Otsuka Pharmaceutical Netherlands B.V.

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat low sodium levels in the blood in adults due to a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat low sodium levels in the blood in adults suffering from syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 7,5 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Accord Healthcare S.L.U.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 15 mg
    tolvaptan 45 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the development of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 15 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (stages 1 to 4) who show signs of rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg
    tolvaptan 60 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with stage 1 to 4 chronic kidney disease who show signs of rapid disease progression. It helps slow the growth of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg
    tolvaptan 90 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat autosomal dominant polycystic kidney disease (ADPKD) in adults with stage 1 to 4 chronic kidney disease who show signs of rapid disease progression. It helps slow the development of cysts in the kidneys, reduces symptoms, and increases urine production.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat low sodium levels in the blood in adults, resulting from a condition called syndrome of inappropriate antidiuretic hormone secretion (SIADH), in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan Igual a 15 mg mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.

  • It is used to treat low sodium levels in the blood in adults suffering from syndrome of inappropriate antidiuretic hormone secretion (SIADH), a condition in which the kidneys retain too much water.

    Form: tablets

    Active substance Dosage
    tolvaptan 30 mg

    ATC: C03X C03XA C03XA01

    Manufacturer: Teva B.V.